MIRC’s primary objective is to improve the treatment options of patients infected with HIV/AIDS by getting hold of novel HIV/AIDS medications in pharmaceutical research. Many patients who cannot afford medications, or who are no longer responding to their medicines have gained access to necessary medical treatments that are either too expensive or not yet commercially available. All these researches have led us to an improved HIV medication regimen that has ensured patients a better quality of life. By participating in these clinical trials, it is also the company’s goal to help the medical community continuously gather pertinent information about the disease and its current and upcoming medications. We believe that it is only through continuous education and research that we can only fully understand the disease, which will hopefully lead us to the ultimate goal – a cure.
MIRC is also expanding its research endeavors to include other infectious diseases, such as Hepatitis C and certain bacterial infections.
Click here to see our services